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1. Introduction
The ACC/AHA Task Force on Practice Guidelines herein revises and updates the original
“Guidelines for Coronary Angiography,” published in 1987 The frequent and still-growing
use of coronary angiography, its relatively high costs, its inherent risks and the ongoing evo‐
lution of its indications have given this revision urgency and priority.
The expert committee appointed included private practitioners and academicians. Commit‐
tee members were selected to represent both experts in coronary angiography and senior
clinician consultants. Representatives from the family practice and internal medicine profes‐
sions were also included on the committee [1].
1.1. Definitions
Coronary angiography is defined as the radiographic visualization of the coronary vessels
after the injection of radiopaque contrast media. The radiographic images are permanently
recorded for future review with either 35 mm cine film or digital recording. Percutaneous or
cutdown techniques, usually from the femoral or brachial artery, are used for insertion of
special intravascular catheters. Coronary angiography further requires selective cannulation
of the ostium of the left and right coronary arteries and, if present, each saphenous vein
graft or internal mammary artery graft to obtain optimal selective contrast injection and
imaging. Numerous specialized catheters have been designed for this purpose. Physicians
performing these procedures must be technically proficient in all aspects of the procedure
and have a complete understanding of the clinical indications and risks of the procedure
and of coronary anatomy, physiology and pathology. It is also important that these physi‐
cians understand the fundamentals of optimal radiographic imaging and radiation safety.
Coronary angiography is usually performed as part of cardiac catheterization, which may
also involve angiography of other vessels or cardiac chambers, and hemodynamic assess‐
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ment as needed for a complete invasive diagnostic evaluation of the individual patient’s car‐
diovascular condition[2,3].
1.2. Purpose
The purpose of coronary angiography is to define coronary anatomy and the degree of lumi‐
nal obstruction of the coronary arteries. Information obtained from the procedure includes
identification of the location, length, diameter, and contour of the coronary arteries; the
presence and severity of coronary luminal obstruction(s); characterization of the nature of
the obstruction (including the presence of atheroma, thrombus, dissection, spasm, or myo‐
cardial bridging), and an assessment of blood flow. In addition, the presence and extent of
coronary collateral vessels can be assessed.
Coronary angiography remains the standard for assessment of anatomic coronary disease,
because no other currently available test can accurately define the extent of coronary lumi‐
nal obstruction. Because the technique can only provide information about abnormalities
that narrow the lumen, it is limited in its ability to accurately define the etiology of the ob‐
struction or detect the presence of nonobstructive atherosclerotic disease.A coronary angiog‐
raphy, which can help diagnose heart conditions, is the most common type of heart catheter
procedure. [2,3]
2. Coronary angiography for specific conditions
2.1. General considerations
Coronary atherosclerosis is a slowly progressive process that can be clinically inapparent for
long periods of time [78–80]. Coronary disease often becomes clinically evident because of
the occurrence of symptoms, such as angina or those associated with MI. Patients with
known CAD are those in whom the disease has been documented by either angiography or
MI. “Suspected coronary disease” means that a patient’s symptoms or other clinical charac‐
teristics suggest a high likelihood for significant CAD and its related adverse outcomes but
that evidence of CAD has not yet been documented as defined above.
Patients may develop symptoms at one point in time but may become asymptomatic there‐
after as the result of a change in the disease or as the result of therapy. For instance, many
patients are symptomatic after an uncomplicated MI, as are patients with mild angina, who
can be rendered asymptomatic by medications. The severity of clinical presentations and the
degree of provocable ischemia on noninvasive testing are the principal factors used in deter‐
mining the appropriateness of coronary angiography.
2.2. Stable angina
Patients with CAD may become symptomatic in many different ways but most commonly
develop angina pectoris. In this document, angina pectoris (or simply angina) means a chest
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discomfort due to myocardial ischemia, often described as a transient squeezing, pressure-
like precordial discomfort. Angina is generally provoked by physical effort (particularly
during the postprandial state), with exposure to cold environment or by emotional stress.
The discomfort on effort is relieved by rest, its duration being a matter of minutes. The ease
of provocation, frequency and duration of episodes may remain relatively unchanged in in‐
dividuals for extended time periods, leading to the term “stable angina pectoris.”
Recommendations for Coronary Angiography in Patients With Nonspecific Chest Pain
Class I
High-risk findings on noninvasive testing. (Level of Evidence: B)
Class IIa: None.
Class IIb:
Patients with recurrent hospitalizations for chest pain who have abnormal (but not high-
risk) or equivocal findings on noninvasive testing. (Level of Evidence: B)
Class III:
All other patients with nonspecific chest pain. (Level of Evidence: C)
2.3. Unstable angina
The acute coronary syndromes include unstable angina, non–Q-wave MI, and acute Q-wave
MI. The diagnosis of unstable angina has been complicated by a broad range of presenta‐
tions that can vary between atypical chest pain and acute MI. An expert panel of clinicians
attempted to clarify the definition of unstable angina in the recently published “Clinical
Practice Guideline for Unstable Angina”[129,130]. Three possible presentations are descri‐
bed:
• Symptoms of angina at rest (usually prolonged 20 minutes);
• New-onset (<2 months) exertional angina of at least CCS class III in severity;
• Recent (<2 months) acceleration of angina as reflected by an increase in severity of at least
one CCS class to at least CCS class III.[4,5]
Variant angina, non–Q-wave MI and recurrent angina24 hours after MI are considered part
of the spectrum of unstable angina. However, in this document, non–Q-wave MI is dis‐
cussed in the section on acute MI. [4,5]
Recommendations for Coronary Angiography in Patients With Postrevascularization Is‐
chemia
Class I
1. Suspected abrupt closure or subacute stent thrombosis after percutaneous revasculari‐
zation. (Level of Evidence: B)
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2. Recurrent angina or high-risk criteria on noninvasive evaluation (Table 5) within nine
months of percutaneous revascularization. (Level of Evidence: C)
Class IIa
1. Recurrent symptomatic ischemia within 12 months of CABG. (Level of Evidence: B)
2. Noninvasive evidence of high-risk criteria occurring at any time postoperatively. (Level
of Evidence:B)
3. Recurrent angina inadequately controlled by medical means after revascularization.
(Level of Evidence: C)
Class IIb
1. Asymptomatic post-PTCA patient suspected of having restenosis within the first
months after angioplasty because of an abnormal noninvasive test but without noninva‐
sive high-risk criteria. (Level of Evidence: B)
2. Recurrent angina without high-risk criteria on noninvasive testing occurring >1 year
postoperatively. (Level of Evidence: C)
3. Asymptomatic postbypass patient in whom a deterioration in serial noninvasive testing
has been documented but who is not high risk on noninvasive testing. (Level of Evidence:
C)
Class III
1. Symptoms in a postbypass patient who is not a candidate for repeat revascularization.
(Level of Evidence: C)
2. Routine angiography in asymptomatic patients after PTCA or other surgery, unless as
part of an approved research protocol. (Level of Evidence: C)
Coronary angiography during the initial management of patients in the emergency de‐
partment
Patients Presenting With Suspected MI and ST- segment Elevation or Bundle-Branch Block
Of all patients who ultimately are diagnosed with acute MI, those resenting with ST-seg‐
ment elevation have been studied most extensively. Patients with ST-segment elevation
have a high likelihood of thrombus occluding the infarct-related artery [6,7]. Considerable
data exist showing that coronary reperfusion can be accomplished either by intravenous
thrombolytic therapy or direct mechanical intervention within the infarct-related artery. Be‐
cause the benefit obtained is directly linked to the time required to reestablish normal distal
blood flow [8–10], rapid triage decisions are mandatory, and delays in instituting reperfu‐
sion therapy must be minimized. The “ACC/AHA Guidelines for the Management of Pa‐
tients with Acute Myocardial Infarction” provide a comprehensive discussion of the
indications, contraindications, advantages, and disadvantages of thrombolytic therapy and
direct coronary angioplasty [11]. Although it is not the purpose of these guidelines to re-ex‐
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amine in detail the merits of these two reperfusion strategies, this is a rapidly evolving area,
and some new information exists.
Recommendations for coronary angiography during the initial management of acute MI
(MI suspected and ST-segment elevation or bundle-branch block present)
Coronary angiography coupled with the intent to perform primary PTCA
Class I
1. As an alternative to thrombolytic therapy in patients who can undergo angioplasty of
the infarct artery within 12 hours of the onset of symptoms or beyond 12 hours if ische‐
mic symptoms persist.
2. In patients who are within 36 hours of an acute ST elevation/Q-wave or new LBBB MI
who develop cardiogenic shock, are less than 75 years of age and revascularization can
be performed within 18 hours of the onset of shock
Class IIa
1. As a reperfusion strategy in patients who are candidates for reperfusion but who have a
contraindication to fibrinolytic therapy, if angioplasty can be performed as outlined
above in class I. (Level of Evidence: C)
Class III
1. In patients who are beyond 12 hours from onset of symptoms and who have no evi‐
dence of myocardial ischemia. (Level of Evidence: A)
2. In patients who are eligible for thrombolytic therapy and are undergoing primary an‐
gioplasty by an unskilled operator in a laboratory that does not have surgical capability.
(Level of Evidence: B)
Recommendations for early coronary angiography in the patient with suspected MI (ST-
segment elevation or BBB present) who has not undergone primary PTCA
Class I: None.
Class IIa: Cardiogenic shock or persistent hemodynamic instability.(Level of Evidence: B)
Class IIb:
1. Evolving large or anterior infarction after Thrombolytic treatment when it is believed
that reperfusion has not occurred and rescue PTCA is planned. (Level of Evidence: B)
2. Marginal hemodynamic status but not actual cardiogenic shock.(Level of Evidence: C)
Class III
1. In patients who have received thrombolytic therapy and have no symptoms of ische‐
mia. (Level of Evidence:A)
2. Routine use of angiography and subsequent PTCA within 24 hours of administration of
thrombolytic agents. (Level of Evidence: A)
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Recommendations for early coronary angiography in acute MI (MI suspected but no st-
segment elevation)
Class I
1. Persistent or recurrent (stuttering) episodes of symptomatic ischemia, spontaneous or
induced, with or without associated ECG changes. (Level of Evidence:A)
2. The presence of shock, severe pulmonary congestion,or continuing hypotension. (Level
of Evidence: B)
Class II: None.
Class III: None.
Hospital-management phase of acute MI
The hospital-management phase of acute MI can encompass several clinical situations. Some
patients with acute MI present too late in their course to be candidates for reperfusion thera‐
py, and in others, the occurrence of infarction may not be appreciated at he time of presenta‐
tion. These groups skip the acute-treatment phase of MI and enter the hospital-management
phase directly. During the hospital management phase, the actions of the clinician are driv‐
en by the consequences of the infarction, such as congestive heart failure, hemodynamic in‐
stability, recurrent ischemia or arrhythmias. Although it is still convenient to divide patients
into those with Q-wave and non–Q-wave infarctions, some indications for coronary angiog‐
raphy are common to all patients with MI regardless of how they have been treated initially
and whether or not Q waves ultimately develop.
Recommendations for use of coronary angiography in patients with valvular heart dis‐
ease Class I
1. Before valve surgery or balloon valvotomy in an adult with chest discomfort, ischemia
by noninvasive imaging, or both. (Level of Evidence: B)
2. Before valve surgery in an adult free of chest pain but with multiple risk factors for cor‐
onary disease. (Level of Evidence: C)
3. Infective endocarditis with evidence of coronary embolization. (Level of Evidence: C)
Class IIa
None.
Class IIb
During left-heart catheterization performed for hemodynamic evaluation before aortic or
mitral valve surgery in patients without preexisting evidence of coronary disease, multiple
CAD risk factors or advanced age. (Level of Evidence: C)
Class III
1. Before cardiac surgery for infective endocarditis when there are no risk factors for coro‐
nary disease and no evidence of coronary embolization. (Level of Evidence: C)
What Should We Know About Prevented, Diagnostic, and Interventional Therapy in Coronary Artery Disease240
2. In asymptomatic patients when cardiac surgery is not being considered. (Level of Evi‐
dence: C)
3. Before cardiac surgery when preoperative hemodynamic assessment by catheterization
is unnecessary, and there is neither preexisting evidence for coronary disease, nor risk
factors for CAD. (Level of Evidence: C)
Congenital heart disease
Although there are no large trials to support its use, coronary angiography is performed in
congenital heart disease for two broad categorical indications. The first indication is to as‐
sess the hemodynamic impact of congenital coronary lesions (375). The second is to assess
the presence of coronary anomalies, which by themselves may be innocent but whose pres‐
ence, if unrecognized, may lead to coronary injury during the correction of other congenital
heart lesions. Congenital anomalies with hemodynamic significance include congenital coro‐
nary artery stenosis or atresia, coronary artery fistula [11], anomalous left coronary artery
arising from the pulmonary artery [12], and anomalous left coronary artery arising from the
right coronary artery or right sinus of Valsalva and passing between the aorta and right ven‐
tricular outflow tract [13]. Patients with congenital coronary stenosis may present with angi‐
na or unexplained sudden death in childhood, whereas patients whose left coronary passes
between the pulmonary artery and aorta often have the same symptoms later in life. Patients
with a coronary arteriovenous fistula often present with a continuous murmur or may have
unexplained angina or congestive heart failure. Anomalous origin of the left coronary artery
from the pulmonary artery should be suspected when there is unexplained MI or heart fail‐
ure in early childhood. Other coronary anomalies of position or origin may cause no physio‐
logic abnormality by themselves. Some, such as origin of the circumflex artery from the
right sinus of Valsalva, are not associated with other congenital anomalies and present only
as incidental findings and are significant only because they complicate the performance and
interpretation of coronary angiograms.
Recommendations for use of coronary angiography in patients with congenital heart dis‐
ease
Class I
1. Before surgical correction of congenital heart disease when chest discomfort or nonin‐
vasive evidence is suggestive of associated CAD. (Level of Evidence: C)
2. Before surgical correction of suspected congenital coronary anomalies such as congeni‐
tal coronary artery stenosis, coronary arteriovenous fistula and anomalous origin of left
coronary artery. (Level of Evidence: C)
3. Forms of congenital heart disease frequently associated with coronary artery anomalies
that may complicate surgical management. (Level of Evidence: C)
4. Unexplained cardiac arrest in a young patient. (Level of Evidence: B)
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Class IIa
Before corrective open heart surgery for congenital heart disease in an adult whose risk pro‐
file increases the likelihood of coexisting coronary disease. (Level of Evidence: C)
Class IIb
During left-heart catheterization for hemodynamic assessment of congenital heart disease in
an adult in whom the risk of coronary disease is not high. (Level of Evidence: C)
Class III
In the routine evaluation of congenital heart disease in asymptomatic patients for whom
heart surgery is not planned. (Level of Evidence: C)
Congestive heart failure
1. Systolic dysfunction
Although it was once believed that myocardial ischemia was either short-lived and resulted
in little or no muscle dysfunction or resulted in infarction with permanent damage, it is now
clear that a middle state may exist in which chronic ischemic nonfunctioning myocardium is
present, to which function may return after myocardial revascularizations [15,16]. This inter‐
mediate state has been termed “myocardial hibernation.” Although most cases of myocar‐
dial dysfunction resulting from CAD are probably irreversible when due to infarction and
subsequent deleterious ventricular remodeling (ischemic cardiomyopathy) [17], some pa‐
tients with hibernating myocardium have been shown to experience a doubling of resting
ejection fraction with resolution of congestive heart failure after coronary revascularization
[18,19]. However, in most cases of hibernation, a more modest improvement in ejection frac‐
tion of 5% occurs after revascularization [20].
2. Diastolic dysfunction
Isolated diastolic dysfunction is the cause of heart failure in 10% to 30% of affected patients.
This disorder is common in older patients with hypertension and often is suspected because of
echocardiographically detected concentric left ventricular hypertrophy, normal systolic func‐
tion and abnormal transmitral flow velocity patterns [21]. However, in some patients with nor‐
mal systolic function, the abrupt onset of pulmonary edema raises the suspicion that transient
ischemia was the cause of decompensation, because elderly patients with hypertension have,
by definition, at least two risk factors for coronary disease. In these patients, who are often too
ill to undergo stress testing, coronary angiography may be necessary to establish or rule out the
diagnosis of ischemically related diastolic dysfunction and heart failure.
Recommendations for use of coronary angiography in patients with congestive heart fail‐
ure
Class I
1. Congestive heart failure due to systolic dysfunction with angina or with regional wall
motion abnormalities and/or scintigraphic evidence of reversible myocardial ischemia
when revascularization is being considered. (Level of Evidence: B)
What Should We Know About Prevented, Diagnostic, and Interventional Therapy in Coronary Artery Disease242
2. Before cardiac transplantation. (Level of Evidence: C)
3. Congestive heart failure secondary to postinfarction ventricular aneurysm or other me‐
chanical complications of MI. (Level of Evidence: C)
Class IIa
1. Systolic dysfunction with unexplained cause despite noninvasive testing. (Level of Evi‐
dence: C)
2. Normal systolic function, but episodic heart failure raises suspicion of ischemically
mediated left ventricular dysfunction. (Level of Evidence: C)
Class III
Congestive heart failure with previous coronary angiograms showing normal coronary ar‐
teries, with no new evidence to suggest ischemic heart disease. (Level of Evidence: C)
1. Aortic dissection
The  need  for  coronary  angiography  before  surgical  treatment  for  aortic  dissection  re‐
mains controversial because there are no large trials to support its use. In young patients
with dissection due to Marfan syndrome or in dissection in peripartum females, coronary
angiography is unnecessary unless there is suspicion that the dissection has affected one
or both coronary ostia. In older patients, in whom dissection is usually related to hyper‐
tension,  coronary angiography is  often necessary,  especially  if  patients  are  suspected of
having coronary disease because of a history of angina or objective evidence of myocar‐
dial ischemia. In patients who have no history of coronary disease, the indications for cor‐
onary  angiography  are  much  less  certain.  Because  of  the  high  incidence  of  coronary
disease in older patients with dissection,  some studies have advocated routine coronary
angiography  [22],  whereas  others  have  found increased  mortality  when  angiography  is
performed [23].
2. Hypertrophic cardiomyopathy
Significant CAD due to atherosclerosis is found in 25% of patients aged >45 years with hy‐
pertrophic cardiomyopathy [26]. Because symptoms due to CAD and hypertrophic cardio‐
myopathy are similar, patients with ischemic symptoms not well controlled with medical
therapy may require coronary angiography to resolve the cause of chest pain. Coronary an‐
giography also is indicated in patients with chest discomfort and hypertrophic cardiomyop‐
athy in whom a surgical procedure is planned to correct outflow tract obstruction.
3. Arteritis
Some patients with inflammatory processes affecting the aorta, such as Takayasu arteritis,
may have coronary artery involvement requiring coronary artery revascularization. In such
patients, coronary angiography is required before the surgical procedure. Kawasaki disease
can result in coronary artery aneurysm and coronary artery stenosis producing myocardial
ischemia or silent occlusion and may require coronary angiographic assessment [24,25].
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4. Chest trauma
Patients who have an acute MI shortly after blunt or penetrating chest trauma may have
atherosclerotic CAD, but coronary artery obstruction or damage has been reported in the ab‐
sence of coronary atherosclerosis [27]. Furthermore, myocardial contusion may simulate
acute MI. Infrequently, coronary angiography is indicated in the management of such pa‐
tients.
Recommendations for use of coronary angiography in other conditions
Class I
1. Diseases affecting the aorta when knowledge of the presence or extent of coronary ar‐
tery involvement is necessary for management (e.g., aortic dissection or aneurysm with
known coronary disease). (Level of Evidence: B)
2. Hypertrophic cardiomyopathy with angina despite medical therapy when knowledge
of coronary anatomy might affect therapy. (Level of Evidence: C)
3. Hypertrophic cardiomyopathy with angina when heart surgery is planned. (Level of
Evidence: B)
Class IIa
1. High risk for coronary disease when other cardiac surgical procedures are planned
(e.g., pericardiectomy or removal of chronic pulmonary emboli). (Level of Evidence: C)
2. Prospective immediate cardiac transplant donors whose risk profile increases the likeli‐
hood of coronary disease. (Level of Evidence: B)
3. Asymptomatic patients with Kawasaki disease who have coronary artery aneurysms on
echocardiography. (Level of Evidence: B)
4. Before surgery for aortic aneurysm/dissection in patients without known coronary dis‐
ease.
5. Recent blunt chest trauma and suspicion of acute MI, without evidence of preexisting
CAD. (Level of Evidence: C)
3. Special considerations regarding coronary angiography
3.1. Accuracy
Cineangiographic images of coronary arteries have been the principal clinical tool for deter‐
mining the severity of coronary luminal stenosis. Modern angiographic equipment has a
resolution of four to five line pairs per millimeter with a six-inch field of view, the usual im‐
age magnification for coronary angiography [28]. Validation studies that use known phan‐
toms show a high correlation between actual size and that measured by quantitative
coronary angiography (QCA) (r = 0.95) [29–32]. The resolution of these phantom studies in‐
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dicates the precision of coronary angiography to be 0.02 to 0.04 mm. Factors that limit reso‐
lution in the clinical setting include grainy films from “quantum mottling” and motion
artifact that, in a clinical setting, limit resolution to 0.2 mm, far less than that realized from
static images of known phantoms. Other factors, such as angulation, overlap of vessels and
image tube resolution can also influence accuracy in the clinical setting. Nevertheless, the
accuracy of coronary angiography does allow for anatomic detail that is not obtainable by
current noninvasive or other invasive technology. Only intravascular ultrasound, which is
discussed in Appendix C, has an image resolution greater than that of coronary angiogra‐
phy. However, intravascular ultrasound cannot visualize the entire coronary tree nor define
the anatomic course of the coronary vessels. It is also limited by shadowing from heavy cal‐
cification and by its inability to image very small vessels or very severe stenosis.
3.2. Digital imaging of coronary angiography
Recent advances in computer storage technology have made feasible digital acquisition,
processing and archival storage of angiographic images obtained during cardiac catheteriza‐
tion. Widespread conversion from cineangiographic film to digital archiving and storage is
anticipated during the next decade. Analog storage technologies such as super VHS video‐
tape and analog optical disks have inadequate resolution to faithfully record coronary an‐
giography. Digital storage methods are generally adequate but until recently have lacked
standardization, which precluded easy exchange of digital angiograms between centers
with different equipment. The development of the Digital Imaging and Communication
standard (DICOM) for cardiac angiography ensures compatibility between equipment from
participating vendors.
In the interventional era, the advantages of digital angiography are important. The image
quality provided by digital angiography is better than any common videotape format. Im‐
provements in computer speed and processing capability enable rapid replay of coronary
injection sequences, as well as evaluation of the results of each intervention and identifica‐
tion of complications such as intraluminal thrombus and dissection. In many laboratories,
the availability of high-quality images during catheterization permits diagnostic and thera‐
peutic catheterization to consist of a single procedure, a capability with significant implica‐
tions for the cost of interventional procedures. Industry sources now estimate that >75% of
existing laboratories are equipped with digital imaging capability.
The ACC Cardiac Catheterization Committee is coordinating efforts to develop and pro‐
mote a standard for archival storage and exchange of digital cardiac angiography. The com‐
mittee has joined in this common cause with an industry organization, the National
Electrical Manufacturers Association (NEMA), and representatives of the American College
of Radiology (ACR). The ACR and NEMA have recently released an interim standard
known as Digital Imaging Communication in Medicine (DICOM version 3.0).
The initial efforts of the standards committee have focused on adoption of a file format and
physical medium for interchange of digital angiographic studies. To transfer images be‐
tween medical centers, the sender would generate a DICOM-compatible file for review by
the receiver. Recently, this working group has chosen a recordable form of the common CD-
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ROM, termed CD-R, as the official exchange medium. Nearly all equipment vendors have
announced support for this format.
3.3. Reproducibility
In clinical practice, the degree of coronary artery obstruction is commonly expressed as the
percent diameter stenosis. This is done by comparing the diameter of the site of greatest nar‐
rowing (minimal lumen diameter) to an adjacent segment assumed to be free of disease. In
clinical practice, the most common method used to estimate the percent diameter narrowing
is subjective visual assessment. Because vasomotor tone can alter the reference diameter, ni‐
troglycerin is frequently administered before angiography to improve the reproducibility of
the measurement. Several studies have shown that measurement of the degree and extent of
luminal narrowing correlates with symptoms as well as with assessments of coronary flow
reserve (CFR) and abnormalities on treadmill exercise testing, perfusion imaging with Tl or
sestamibi, stress echocardiography and fast computerized tomography [33– 37]. In addition,
the percent diameter reduction and the number of stenosis of >50% to 70% correlate with
long-term outcome [33–37].
3.4. Limitations
Although coronary angiography is considered the reference standard for anatomic assess‐
ment of coronary obstructions, there are limitations to the technique. When luminal narrow‐
ings are present on coronary angiography (in the absence of spasm), pathological analyses
almost always demonstrate severe atherosclerotic obstruction. Even minor angiographic ab‐
normalities are associated with a poorer long-term outcome than are completely normal ap‐
pearing angiograms. Coronary angiography has a high predictive value for the presence of
CAD when abnormalities are present. However, the converse is not true. A normal coronary
angiogram does not exclude atherosclerosis, and in fact, most pathological studies suggest
that angiography grossly underestimates the extent and severity of atherosclerosis [38–42].
Several factors contribute to this discrepancy.
First, angiography depicts coronary anatomy from a planar two-dimensional silhouette of
the contrast-filled vessel lumen. However, coronary lesions are often geometrically complex,
with an eccentric luminal shape such that one angle of view may misrepresent the extent of
narrowing [39]. Two orthogonal angiograms should demonstrate more correctly the severity
of most lesions, but adequate orthogonal views are frequently unobtainable because the
stenosis may be obscured by overlapping side branches, disease at bifurcation sites, dio‐
graphic foreshortening or tortuosity. This can be especially difficult in the left main coronary
artery, where identifying a significant stenosis is of utmost clinical importance [43].
Second, an adaptive phenomenon, coronary remodeling,” contributes to the inability of cor‐
onary angiography to identify mild atherosclerosis [44]. Remodeling was initially observed
on histology as the outward displacement of the external vessel wall in vascular segments
with significant atherosclerosis. In the early phases of atherosclerosis, this vessel enlarge‐
ment “compensates” for luminal encroachment, thereby concealing the atheroma from the
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angiogram. When the atherosclerotic plaque becomes severe, luminal encroachment be‐
comes evident. Although such mild lesions do not restrict blood flow, clinical studies have
demonstrated that these minimal or even unseen angiographic lesions represent an impor‐
tant predisposing cause of acute coronary syndromes, including MI [55].
Third, assessment of luminal diameter narrowing is complicated by the frequent absence of
a normal reference segment[56]. Angiography visualizes only the lumen of the vessel and
cannot determine if the wall of the reference segment has atherosclerosis [38–42]. In the
presence of diffuse reference segment disease, percent stenosis will predictably underesti‐
mate the true amount of diameter narrowing.
Finally, in the setting of percutaneous intervention, the assumptions underlying simple pro‐
jection imaging of the lumen are further impaired. Necropsy studies and intravascular ultra‐
sound demonstrate that most mechanical coronary interventions exaggerate the extent of
luminal eccentricity by fracturing or dissecting the atheroma within the lesion [45– 49]. The
angiographic appearance of the postintervention vessel often consists of an enlarged, al‐
though frequently “hazy” lumen [46]. In this setting, the lumen size on angiography may
overestimate the vessel cross-sectional area and misrepresent the actual gain in lumen size.
Experimental and clinical studies have shown that when percent stenosis is >50%, the ability
to increase blood flow in response to metabolic demands is impaired [50]. This augmenta‐
tion of coronary blood flow to demand is termed the coronary flow reserve. Determination
of CFR requires measurement of blood flow at rest and after induction of reactive hypere‐
mia, usually by administration of a coronary vasodilator. Several methods for measurement
of CFR in patients have been developed, including intracoronary Doppler flow probes, digi‐
tal angiography and quantitative PET [51– 54].
Coronary collaterals can provide significant additional blood flow to territories served by
stenotic vessels [58]. In general, collaterals are not evident unless resting ischemia is present,
such as that which occurs with a stenosis.90%. In many patients, collateral flow merely re‐
stores normal resting blood flow but does not provide adequate flow when metabolic de‐
mand increases. The presence of collaterals, however, is associated with preservation of
myocardial function after MI, reduced myocardial ischemia on noninvasive stress testing,
and reduced ischemia during angioplasty [59,60]. Paradoxically, a greater ischemic response
on noninvasive functional testing with adenosine than with exercise has been reported in
the presence of collaterals, presumably due to an increase in the coronary steal phenomenon
[61]. Collateral blood flow can only be semiquantified by angiography [62], and precise as‐
sessment of perfusion by angiography is poor. This inability to adequately measure collater‐
al flow is one of the factors that prevent accurate assessment of the functional significance of
coronary stenosis by angiography alone [57].
3.5. Contrast agents
For an understanding of the pharmacologic properties and adverse effects of contrast
agents, the reader is referred to the 1993 review of the subject by the ACC Cardiovascular
Imaging Committee [63] and the 1996 review by Hirshfeld [64].
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Except for a less potent anticoagulant effect, nonionic agents are better tolerated and have
fewer side effects than ionic agents [63]. Several randomized trials have compared their use
during cardiac angiography. Barrett et al. [65] compared a nonionic low-osmolar contrast
agent with an ionic high-osmolar contrast agent. Although adverse events were reduced, se‐
vere reactions were confined to patients with underlying severe cardiac disease. These au‐
thors supported the use of nonionic low-osmolar agents in these high-risk patients.
Steinberg et al. [66]
The difference in the incidence of any major contrast reaction is proportional to the New
York Heart Association clinical function class, rising from 0.5% for class I patients to 3.6%
for class IV patients [68]. Given these observations, it has been suggested that nonionic
agents should be reserved for patients who are at high risk for adverse reactions and that
ionic agents should be used for all other patients [64].
Factors that have been associated with high risk of adverse reactions to contrast media in‐
clude prior adverse reaction to contrast agents, age >65 years, New York Heart Association
functional class IV (or hemodynamic evidence of congestive heart failure), impaired renal
function (creatinine >2.0 mg/dL), acute coronary syndromes (unstable angina or acute MI)
and severe valvular disease (aortic valve area <0.7 cm2 or mitral valve area <1.25 cm2) [64]. It
is recommended that the individual practitioner appropriately assess the cost and benefit re‐
lationship when selecting contrast agents in any individual patient and that a strategy of re‐
serving nonionic agents for patients who are at high risk of adverse reactions is prudent and
cost-effective.[69]
ACC/AHA classifications of class I, II, and III. These classes summarize the indications
for coronary angiography as follows:
Class I: Conditions for which there is evidence and/or general agreement that this proce‐
dure is useful and effective.
Class II:  Conditions for which there is conflicting evidence and/or a divergence of opin‐
ion  about  the  usefulness/efficacy  of  performing the  procedure.  Class  IIa:  Weight  of  evi‐
dence/opinion is in favor of usefulness/ efficacy. Class IIb:  Usefulness/efficacy is less well
established by evidence/opinion. Class III:  Conditions for which there is evidence and/or
general  agreement  that  the  procedure  is  not  useful/effective  and in  some cases  may be
harmful.[70,71]
Coronary angiography indications
• Unstable angina or Chest pain [uncontrolled with medications or after a heart attack]
• Heart attack
• Aortic Stenosis
• Before a bypass surgery
• Abnormal treadmill test results
• Determine the extent of coronary artery disease
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• Disease of the heart valve causing symptoms (syncope, shortness of breath)
• To monitor rejection in heart transplant patients
• Syncope or loss of consciousness in patients with aortic valve disease
• Pain in the Jaw,Neck or Arm
Risks
• Generally the risk of serious complications ranges from 1 in 1,000 to 1 in 500. Risks of the
procedure include the following :
• Stroke
• Heart attack
• Irregular heart beats
• Low blood pressure
• Injury to the coronary artery
• Allergic reaction to contrast dye[3]
Rare risks and complications include:
• Need for emergency heart surgery or angioplasty.
• A stroke.
• Heart attack.
• Surgical repair of the groin/arm puncture site or blood vessel.
• Abnormal heart rhythm that continues for a long time. This may need an electric shock to
correct.
• An allergic reaction to the x-ray dye.[2]
Other, less common complications include:
• Arrhythmias. These irregular heartbeats often go away on their own. However, your doc‐
tor may recommend treatment if they persist.
• Kidney damage caused by the dye that’s used during the test.
• Blood clots that can trigger a stroke,heart stroke, or other serious problems.
• Low blood pressure.[2]
Coronary angiography contraindications
• Fever
• Kidney failure or dysfunction
• Problems with blood coagulation (Coagulopathy)
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• Active systemic infection
• Uncontrolled Blood Pressure (Hypertension)
• Allergy to contrast (dye) medium
• Transient Ischemic attack
• Severe anemia
• Electrolyte imbalance
• Uncontrolled rhythm disturbances (arrhythmias)
• Uncompensated heart failure[4]
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